TickerLeague

Capital Expenditures for Becton, Dickinson and (BDX)

According to Becton, Dickinson and's latest reported financial statements, the company's current capital expenditures (TTM) is $763.00M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Currently viewingCapital Expenditures

Latest period

$763.00M

YoY change

+4.8%

5Y CAGR

-1.3%

Peak year (2021)

$1.23B

Cumulative capital expenditures

$19.96B

CapEx history chart for Becton, Dickinson and (BDX) from 1989 to 2025

CapEx history table for Becton, Dickinson and (BDX) from 1989 to 2025

Fiscal yearPeriod endedReportedCapital ExpendituresYoY
2025$760.00M+4.8%
2024$725.00M-17.0%
2023$874.00M-10.2%
2022$973.00M-21.0%
2021$1.23B+52.0%
2020$810.00M-15.4%
2019$957.00M+6.9%
2018$895.00M+23.1%
2017$727.00M+1.3%
2016$718.00M+13.4%
2015$633.00M-3.1%
2014$653.00M+11.1%
2013$588.00M+6.2%
2012$553.64M-8.5%
2011$605.26M-4.3%
2010$632.47M-9.7%
2009$700.69M+7.6%
2008$651.29M+12.5%
2007$578.73M+20.0%
2006$482.10M+51.8%
2005$317.63M+19.5%
2004$265.72M+1.8%
2003$261.04M+0.5%
2002$259.70M-30.0%
2001$370.75M-1.5%
2000$376.37M-45.1%
1999$685.80M-4.5%
1998$717.90M+93.5%
1997$371.10M+128.5%
1996$162.40M+27.3%
1995$127.60M-6.0%
1994$135.80M-26.3%
1993$184.20M-0.8%
1992$185.60M-12.1%
1991$211.10M-19.9%
1990$263.60M-16.2%
1989$314.40M

CapEx values are taken from Becton, Dickinson and's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual capital expenditures for Becton, Dickinson and (BDX) came in at $760.00M – edged up 4.8% year-over-year.

Becton, Dickinson and capital expenditures has contracted on net over the period, with a -1.3% compound annual growth rate over 2020–2025 (5 years).

Becton, Dickinson and capital expenditures plunged from $1.23B in 2021 to $760.00M in 2025, a 38.3% drawdown.

$1.23B stands as the all-time-high annual capital expenditures, posted in 2021, against a low of $127.60M during 1995.

Becton, Dickinson and (BDX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.

Becton, Dickinson and Capital Expenditures by Year

Becton, Dickinson and Capital Expenditures 2025: $760.00M

Becton, Dickinson and capital expenditures in 2025 was $760.00M, edged up 4.8% from 2024.

Becton, Dickinson and Capital Expenditures 2024: $725.00M

Becton, Dickinson and capital expenditures in 2024 was $725.00M, declined 17.0% below 2023.

Becton, Dickinson and Capital Expenditures 2023: $874.00M

Becton, Dickinson and capital expenditures in 2023 was $874.00M, declined 10.2% below 2022.

Becton, Dickinson and Capital Expenditures 2022: $973.00M

Becton, Dickinson and capital expenditures in 2022 was $973.00M, declined 21.0% below 2021.

Becton, Dickinson and Capital Expenditures 2021: $1.23B

Becton, Dickinson and capital expenditures in 2021 was $1.23B.

See more financial history for Becton, Dickinson and (BDX).

Sector peers — CapEx

Companies in the same sector as Becton, Dickinson and, ranked by their latest capital expenditures.

CompanyCapital ExpendituresSector
Novo Nordisk A/S (NVO)$90.11BHealthcare
Eli Lilly and Company (LLY)$7.84BHealthcare
Johnson & Johnson (JNJ)$4.83BHealthcare
Merck & Co., Inc. (MRK)$4.11BHealthcare
UnitedHealth Group Incorporated (UNH)$3.62BHealthcare
AstraZeneca PLC (AZN)$2.81BHealthcare
Amgen Inc. (AMGN)$1.86BHealthcare
AbbVie Inc. (ABBV)$1.21BHealthcare

Frequently asked questions

What is Becton, Dickinson and's capital expenditures?

Latest reported capital expenditures for Becton, Dickinson and (BDX) is $763.00M (period ending December 31, 2025).

How has Becton, Dickinson and capital expenditures changed year-over-year?

Becton, Dickinson and (BDX) capital expenditures changed +4.8% year-over-year on the latest annual filing.

What is the long-term growth rate of Becton, Dickinson and capital expenditures?

Becton, Dickinson and (BDX) capital expenditures compound annual growth rate is -1.3% over the most recent 5 years available.

When did Becton, Dickinson and capital expenditures hit its highest annual value?

Becton, Dickinson and capital expenditures reached its highest annual value of $1.23B in 2021.

What was Becton, Dickinson and capital expenditures in 2024?

Becton, Dickinson and (BDX) capital expenditures in 2024 was $725.00M.

What was Becton, Dickinson and capital expenditures in 2025?

Becton, Dickinson and (BDX) capital expenditures in 2025 was $760.00M.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.